Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/16 → 31/03/17 |
Funding
- Rivkin Center for Ovarian Cancer: A$97,935.00
PPARgamma Activation Augments Anticancer Effects of XIAP Inhibition in Ovarian Granulosa Cell Tumors
- Chu, Simon (Primary Chief Investigator (PCI))
- Fuller, Peter (Chief Investigator (CI))
Project: Research